CLIA
Eremid Genomic Services Receives CLIA Accreditation for New Lab
Kannapolis, North Carolina-based Eremid was acquired by venture firm Coddle Creek Capital in September.
The company will offer diagnostics including a test for the early detection of pancreatic cancer out of the lab as well as pharma research services.
If the Center for Genomic Interpretation's in silico quality assessment catches on with payors, some labs are sure to push back or propose data sharing as an alternative.
Bionano Genomics Launches CLIA-Certified Laboratory, First OGM-Based Test
Bionano Laboratories will offer services to clinical customers seeking to implement OGM for routine diagnostic use.
Bluestar Genomics Gets CLIA Certification
The company said that the certification will enable it to perform its epigenomic pancreatic cancer test within its own laboratory.
Apr 27, 2022
Neogen Obtains CLIA Certification for Genomics Lab
Mar 30, 2021
Binx Health Chlamydia and Gonorrhea Test CLIA Waived
Dec 10, 2020
Lucence Obtains CLIA Certification for Palo Alto Lab
Nov 11, 2020
Jan 29, 2020
IDbyDNA Raises $20M in Series B Financing
Oct 14, 2019
Avellino Labs Gets CLIA Certification
Feb 25, 2019
Jan 30, 2019
Oct 25, 2018
Abbott Molecular Flu, Strep Tests Get FDA Clearance
Jul 26, 2018